Robot Programming from a Single Demonstration for High Precision Industrial Insertion

por Wang, Kaimeng, Fan, Yongxiang, Sakuma, Ichiro
Publicado 2023

Dispersive coherent Brillouin scattering spectroscopy

por Ishijima, Ayumu, Okabe, Shinga, Sakuma, Ichiro, Nakagawa, Keiichi
Publicado 2022

Effect of PEGylation on the Drug Release Performance and Hemocompatibility of Photoresponsive Drug-Loading Platform

por Mizuno, Hayato L., Anraku, Yasutaka, Sakuma, Ichiro, Akagi, Yuki
Publicado 2022

Occlusion-robust scene flow-based tissue deformation recovery incorporating a mesh optimization model

por Chen, Jiahe, Hara, Kazuaki, Kobayashi, Etsuko, Sakuma, Ichiro, Tomii, Naoki
Publicado 2023

Angiotensin converting enzyme inhibitors remain the first treatment of choice

por Oh, Pyung Chun, Sakuma, Ichiro, Hayashi, Toshio, Koh, Kwang Kon
Publicado 2016

Corrigendum: The effects of pemafibrate and Omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, pa...

por Takeda, Yasutaka, Sakuma, Ichiro, Hiramitsu, Shinya, Okada, Mizuho, Ueda, Shinichiro, Sakurai, Masaru
Publicado 2023

Potential favorable action of sodium-glucose cotransporter-2 inhibitors on sudden cardiac death: a brief overview

por Sato, Tatsuya, Kouzu, Hidemichi, Yano, Toshiyuki, Sakuma, Ichiro, Furuhashi, Masato, Tohse, Noritsugu
Publicado 2023

Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events

por Koh, Kwang Kon, Sakuma, Ichiro, Shimada, Kazunori, Hayashi, Toshio, Quon, Michael J.
Publicado 2017

Investigating the optimum size of nanoparticles for their delivery into the brain assisted by focused ultrasound-induced blood–brain barrier opening

por Ohta, Seiichi, Kikuchi, Emi, Ishijima, Ayumu, Azuma, Takashi, Sakuma, Ichiro, Ito, Taichi
Publicado 2020

Study protocol of the PROUD48 study comparing the effects of pemafibrate and omega-3 fatty acid ethyl esters on ApoB-48 in statin-treated patients with dyslipidaemia: a prospective...

por Takeda, Yasutaka, Sakuma, Ichiro, Hiramitsu, Shinya, Okada, Mizuho, Ueda, Shinichiro, Sakurai, Masaru
Publicado 2022

The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group...

por Takeda, Yasutaka, Sakuma, Ichiro, Hiramitsu, Shinya, Okada, Mizuho, Ueda, Shinichiro, Sakurai, Masaru
Publicado 2023

Hypertriglyceridemia and Cardiovascular Diseases: Revisited

por Han, Seung Hwan, Nicholls, Stephen J, Sakuma, Ichiro, Zhao, Dong, Koh, Kwang Kon
Publicado 2016

Efficacy and safety of sitagliptin treatment in older adults with moderately controlled type 2 diabetes: the STREAM study

por Nagao, Mototsugu, Sasaki, Jun, Sugihara, Hitoshi, Tanimura-Inagaki, Kyoko, Harada, Taro, Sakuma, Ichiro, Oikawa, Shinichi
Publicado 2023

Applicability of a single camera-based catheter navigation system using teeth arch as an anatomical landmark for superselective intraarterial infusion in advanced oral cancer treat...

por Yanagida, Ken, Ohya, Takashi, Wang, Junchen, Iwai, Toshinori, Izumi, Toshiharu, Kobayashi, Etsuko, Sakuma, Ichiro, Mitsudo, Kenji
Publicado 2021

Analysis of carotid artery deformation in different head and neck positions for maxillofacial catheter navigation in advanced oral cancer treatment

por Ohya, Takashi, Iwai, Toshinori, Luan, Kuan, Kato, Takashi, Liao, Hongen, Kobayashi, Etsuko, Mitsudo, Kenji, Fuwa, Nobukazu, Kohno, Ryuji, Sakuma, Ichiro, Tohnai, Iwai
Publicado 2012

Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial

por Morimoto, Takeshi, Sakuma, Ichiro, Sakuma, Mio, Tokushige, Akihiro, Natsuaki, Masahiro, Asahi, Tomohiro, Shimabukuro, Michio, Nomiyama, Takashi, Arasaki, Osamu, Node, Koichi, Ueda, Shinichiro
Publicado 2019

Author Correction: Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical...

por Morimoto, Takeshi, Sakuma, Ichiro, Sakuma, Mio, Tokushige, Akihiro, Natsuaki, Masahiro, Asahi, Tomohiro, Shimabukuro, Michio, Nomiyama, Takashi, Arasaki, Osamu, Node, Koichi, Ueda, Shinichiro
Publicado 2020

Comorbidities Associated With Residual Cardiovascular Risk in Patients With Chronic Coronary Syndrome Receiving Statin Therapy　― Subanalysis of the REAL-CAD Trial ―

por Wakabayashi, Kohei, Suzuki, Hiroshi, Fukumoto, Yoshihiro, Obara, Hitoshi, Kakuma, Tatsuyuki, Sakuma, Ichiro, Kimura, Takeshi, Iimuro, Satoshi, Daida, Hiroyuki, Shimokawa, Hiroaki, Nagai, Ryozo
Publicado 2022

Preclinical ultrasound image-guided high intensity focused ultrasound robot system for breast cancer therapy

por Azuma, Takashi, Sugiyama, Ryusuke, Matsui, Kazuhiro, Fujiwara, Keisuke, Takeuchi, Hideki, Itani, Kazunori, Yoshinaka, Kiyoshi, Sasaki, Akira, Takagi, Shu, Sakuma, Ichiro, Matsumoto, Yoichiro, Iwahashi, Toshihide
Publicado 2015

Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving st...

por Furuhashi, Masato, Sakuma, Ichiro, Morimoto, Takeshi, Higashiura, Yukimura, Sakai, Akiko, Matsumoto, Megumi, Sakuma, Mio, Shimabukuro, Michio, Nomiyama, Takashi, Arasaki, Osamu, Node, Koichi, Ueda, Shinichiro
Publicado 2020